Provenance Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$197K Buy
1,532
+1,322
+630% +$155K 0.02% 139
2026
Q1
$25.3K Sell
210
-60
-22% -$6.93K ﹤0.01% 256
2025
Q4
$28.4K Sell
270
-100
-27% -$9.39K ﹤0.01% 235
2025
Q3
$31.1K Hold
370
﹤0.01% 253
2025
Q2
$29.3K Sell
370
-1,290
-78% -$103K ﹤0.01% 245
2025
Q1
$149K Sell
1,660
-5,110
-75% -$477K 0.02% 148
2024
Q4
$673K Buy
6,770
+6,400
+1,730% +$660K 0.09% 66
2024
Q3
$42K Buy
370
+100
+37% +$11.9K 0.01% 244
2024
Q2
$33.4K Sell
270
-100
-27% -$12.9K ﹤0.01% 229
2024
Q1
$48.8K Sell
370
-130
-26% -$16K 0.01% 226
2023
Q4
$54.5K Buy
500
+270
+117% +$28K 0.01% 199
2023
Q3
$23.7K Buy
+230
New +$24.8K ﹤0.01% 211

Other funds holding MRK

Provenance Wealth Advisors's MRK Position: Q2 2026 in Review

Provenance Wealth Advisors increased its Merck (MRK) stake by 630% in Q2 2026, buying an estimated $155K and bringing the position to 1,532 shares worth $197K. The position accounts for 0.02% of the portfolio, ranked #139.

Provenance Wealth Advisors first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $673K in Q4 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Provenance Wealth Advisors held 1,532 shares of Merck worth $197K as of Q2 2026.
  • Provenance Wealth Advisors bought 1,322 Merck shares in Q2 2026, an estimated $155K.
  • Merck made up 0.02% of Provenance Wealth Advisors's portfolio in Q2 2026, its #139 holding.
  • Provenance Wealth Advisors first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • Provenance Wealth Advisors's Merck position peaked at $673K in Q4 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.